POST Online Media Lite Edition



 

Pfizer, BioNTech file for coronavirus vaccine approval in Europe

Christian Fernsby |
Pfizer Inc. and partner BioNTech SE said they are seeking approval from the European Union for their coronavirus vaccine.

Article continues below




The companies, which have already applied for authorization in the U.S. and U.K., submitted an application on Monday to the European Medicines Agency. That application was accepted on Tuesday by the regulator, the companies said.

The submission marked a milestone in the race to supply the world with a working vaccine to end the pandemic, said Ugur Sahin, the chief executive of BioNTech.

The companies have already filed similar submissions with the U.S. Food and Drug Administration and Britain's Medicines and Healthcare Products Regulatory Agency. Their vaccine is being reviewed in other countries, including Canada, Japan and Australia.


What to read next

Pfizer and BioNTech share positive early data on mRNA vaccine candidate BNT162b2 against coronavirus
Sanofi and BioNTech in multiyear exclusive agreement
EU to purchase up to 300 mln doses of BioNTech Pfizer vaccine